This new initiative is focused on using behavioral measures and computational methods to define novel clinical signatures that can be used for individual-level prediction and clinical decision making in treating mental disorders. This study, titled, “Phenotypes REimagined to Define Clinical Treatment and Outcome Research (PREDiCTOR)”, will use objective, scalable, and cost-effective measurements to define novel clinical signatures that can be used for individual-level prediction and clinical decision-making in treating mental health disorders. This pilot study will explore the safety, feasibility, clinical effects and mechanism of deep brain stimulation in the substantia nigra pars reticulata (SNr DBS) in 5 patients with treatment resistant schizophrenia. The pilot study will primarily investigate safety of the DBS surgical procedure and chronic stimulation, compliance with postsurgical care, follow-up DBS programing and research visits, and home-based procedures, including managing the DBS patient-controller and daily recordings of DBS sensing, symptom severity and audiovisual measures. Secondary outcomes are DBS related clinical changes, including hallucinations, delusions, negative symptoms and cognitive function, and optional intraoperative measures including acute symptom changes, electrophysiology, dopamine voltammetry, and brain biopsy.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level
Education Level
Ph.D. or professional degree